Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canntab Therapeutics Ltd CTABF

Canntab Therapeutics Limited is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The Company’s operations comprise a single segment engaged in the medical marijuana business. The Company’s hard pill cannabinoid formulations provide doctors, patients, and consumers with medical grade solutions. These include once a day and extended-release formulations. Its products include INSTANT RELEASE - (IR Tablet), EXTENDED-RELEASE - (XR Tablet), and ORAL DISSOLVING - O.D. Tablet (ODT). The IR Tablet is a release profile for solid hard tablets. The XR Tablet is a phytocannabinoid vehicle that is designed to directly address the drawbacks and challenges of competing oral delivery systems. ODT is specifically designed to dissolve directly in the patient’s mouth, with an onset of action between five and thirty minutes.


GREY:CTABF - Post by User

Canntab Therapeutics Ltd > Confused
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(8)
•••
Comment by Tonydeon Apr 21, 2018 6:49pm
134 Views
Post# 27922299

RE:Confused

RE:Confused
bmansinho, in a case like this all shareholders hope that the opening bid will be equivalent to the closing price. That's not always the case as we experience on Friday. Now the thing that puzzle me is the $4.00 opening bid that so many investors on these boards mentioned in these last few weeks. Correct me if I'm wrong, Canntab Shares were offered at $4.00 each. If you go back to the LOI we (TFS shareholders) had to give up 200 Old Shares for One (1) New Share. While Canntab Shareholders received four (4) New Shares for One (1) Old Share. In other words $4.00 was offered for Canntab's Old Share, which means it has to be divided by 4. So, although I'm disappointed loosing a lot of money, I wasn't surprise with the opening bid. For sure there's going to be a long wait to get my (our) money back. Hopefully between Canntab and the other seven (7) SpinCos the wait will get shorter. I'm pretty convinced that at least three (3) out of the seven (7) will prosper, and maybe even reap some profits, within the next year or so. Those are only my thoughts. Please don't get me wrong, I wish that "PILL" share price will, at least, reflect the real worth of the company, and in my opinion, at this point it is worth low 2's. GLTA.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities